Head 'International Liason Office and Conferences', Executive Department ‘European Union and International Affairs’, Federal Institute for Drugs and Medical Devices (BfArM), DE
Peter Bachmann has joint in 1999 the Federal Institute for Drugs and Medical Devices (BfArM, Germany), Department of ‘Drug Approval’. He was in the following years the head of several subunits and units responsible for the variation and authorisation of medicinal product in the framework of MRP, including the task of the German representative to the MRFG (Mutual Recognition Facilitation Group). Following the reorganisation of the BfArM in July 2005, Peter Bachmann was appointed as Senior Expert for ‘European Drug Regulatory Affairs’ at Department ‘European and International Affairs’. He was the appointed German CMDh member until November 2011 and served as elected CMDh Chair from November 2011 till November 2017. His current position is the Head of ‘International Liason Office and Conferences at BfArM, the German Member of the NtA, a member of the EUNDB and the SPOR Task Force, ), a member of the HMA WG ‘Better Use of Medicines’ (incl the ePI Task Force), a member of the International Pharmaceutical Regulators Programme (IPRP) Management Committee (since 2018), the European Lead of the ICH GDG (Generic Discussion Group) and member of different other European and International AdHoc Working Parties.. His is a lecturer for „Drug Regulatory Affairs‟ at several Universities (Bonn, Duisburg, Basel, Copenhagen), a Honorary Member of the Middle-European Society for Regulatory Affairs (MEGRA), a Honorary Lifetime Member of TOPRA, a former member and Vice-Chair of the DIA Advisory Committee Europe (2007 – 2013), DIA Board of Directors (2013 – 2016) and is currently serving at the DIA Council of Regulators and the TOPRA Advisory Committee.